McCombe William D.
- SEC CIK
- 0001878824
No open-market purchases or sales filed in the past year.
Current role at each company
- CTKB Cytek Biosciences, Inc.Chief Financial Officeras of Aug 20, 2026
- VELO Velo3D, Inc.Chief Financial Officeras of Aug 23, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McCombe William D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CTKB Cytek Biosciences, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2025 (view filing) | Jun 2 | 1 day | McCombe William D.Chief Financial Officer | PPurchase | +35.0K | $2.78 | +$97.3K | +168.7%55.7K after |
VELO Velo3D, Inc.
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2023 (view filing) | Aug 21 | 2 days | McCombe William D.Chief Financial Officer | SSale | −11.2K | $1.49 | −$16.7K | −6.2%170.0K after | |
| May 16, 2023 (view filing) | May 15 | 1 day | McCombe William D.Chief Financial Officer | SSale | −11.2K | $1.86 | −$20.8K | −6.9%150.5K after | |
| Feb 17, 2023 (view filing) | Feb 15 | 2 days | McCombe William D.Chief Financial Officer | SSale | −4.27K | $3.62 | −$15.5K | −3.2%130.9K after | |
| Dec 14, 2022 (view filing) | Nov 16 | 28 daysLate | McCombe William D.Chief Financial Officer | SSale | −14.5K | $2.61 | −$37.8K | −10.4%125.3K after |